MediPal Holdings Corporation

OTCPK:MAHL.Y Stock Report

Market Cap: US$3.1b

MediPal Holdings Past Earnings Performance

Past criteria checks 5/6

MediPal Holdings has been growing earnings at an average annual rate of 5.2%, while the Healthcare industry saw earnings growing at 5.7% annually. Revenues have been growing at an average rate of 2.3% per year. MediPal Holdings's return on equity is 7.5%, and it has net margins of 1.3%.

Key information

5.2%

Earnings growth rate

5.8%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate2.3%
Return on equity7.5%
Net Margin1.3%
Next Earnings Update10 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How MediPal Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MAHL.Y Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,604,41546,047184,0830
30 Jun 243,581,31239,294188,0120
31 Mar 243,558,73241,474185,6770
31 Dec 233,507,50537,244178,3600
30 Sep 233,453,60138,636177,3410
30 Jun 233,408,41741,724167,2920
31 Mar 233,360,00838,806163,1430
31 Dec 223,351,06930,439165,2300
30 Sep 223,333,07328,222161,0210
30 Jun 223,304,37228,248160,2790
31 Mar 223,290,92129,423159,4870
31 Dec 213,279,58336,411158,3000
30 Sep 213,265,95130,523158,6340
30 Jun 213,241,83826,468160,9950
31 Mar 213,211,12523,926162,9080
31 Dec 203,208,23726,682166,8750
30 Sep 203,186,65133,329168,4720
30 Jun 203,236,31537,002169,7430
31 Mar 203,253,07937,968171,1350
31 Dec 193,242,84034,722170,2260
30 Sep 193,253,49535,443170,7530
30 Jun 193,189,61334,116170,7880
31 Mar 193,181,92834,359171,1520
31 Dec 183,178,57834,315171,1010
30 Sep 183,169,34434,122171,4980
30 Jun 183,169,21637,166170,4460
31 Mar 183,146,31434,780170,5820
31 Dec 173,124,72433,199170,5180
30 Sep 173,093,74331,086169,5170
30 Jun 173,072,59726,239169,0380
31 Mar 173,063,90029,011167,8530
31 Dec 163,065,83332,149168,9600
30 Sep 163,072,86832,201167,8790
30 Jun 163,057,50133,965166,2920
31 Mar 163,028,18730,771164,5740
31 Dec 152,995,21028,449159,8180
30 Sep 152,953,70726,052158,5980
30 Jun 152,923,06123,938157,9620
31 Mar 152,872,90523,687158,3480
31 Dec 142,902,88922,221160,8750
30 Sep 142,909,85821,592161,9710
30 Jun 142,920,80822,231162,8760
31 Mar 142,947,79825,485163,1750

Quality Earnings: MAHL.Y has high quality earnings.

Growing Profit Margin: MAHL.Y's current net profit margins (1.3%) are higher than last year (1.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MAHL.Y's earnings have grown by 5.2% per year over the past 5 years.

Accelerating Growth: MAHL.Y's earnings growth over the past year (19.2%) exceeds its 5-year average (5.2% per year).

Earnings vs Industry: MAHL.Y earnings growth over the past year (19.2%) exceeded the Healthcare industry 10.2%.


Return on Equity

High ROE: MAHL.Y's Return on Equity (7.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 02:05
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MediPal Holdings Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.